Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Capra

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cellular and Molecular Life Sciences : CMLS|January 8, 2011
Light on the structure of thromboxane A₂receptor heterodimersFrancesca Fanelli, Mario Mauri, Valérie Capra, et al.
Plos One|April 5, 2013
Full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and G protein activationValérie Capra, Marta Busnelli, Alessandro Perenna, et al.
European Journal of Pharmacology|August 19, 2003
Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferationValérie Capra, Aïda Habib, Maria Rosa Accomazzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2006
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparationsCarola Buccellati, Angelo Sala, Giuseppe Rossoni, et al.
Biochemical Pharmacology|November 11, 2005
CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptorsLiaman Mamedova, Valérie Capra, Maria Rosa Accomazzo, et al.
Pharmacological Research|December 2, 2015
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibitionMalvina Hoxha, Carola Buccellati, Valérie Capra, et al.
Biochemical Pharmacology|November 16, 2016
Impaired thromboxane receptor dimerization reduces signaling efficiency: A potential mechanism for reduced platelet function in vivoValérie Capra, Mario Mauri, Francesca Guzzi, et al.
Molecular Diagnosis & Therapy|December 13, 2006
G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveMiles D Thompson, Jun Takasaki, Valérie Capra, et al.
Prostaglandins & Other Lipid Mediators|April 4, 2015
Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT₂ receptorValérie Capra, Chiara Carnini, Maria Rosa Accomazzo, et al.
Chemmedchem|August 7, 2012
Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitorsMassimo Bertinaria, Mohammed Abrar Abdul Gaffar Shaikh, Carola Buccellati, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Life Sciences : CMLS|January 8, 2011
Light on the structure of thromboxane A₂receptor heterodimersFrancesca Fanelli, Mario Mauri, Valérie Capra, et al.
Plos One|April 5, 2013
Full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and G protein activationValérie Capra, Marta Busnelli, Alessandro Perenna, et al.
European Journal of Pharmacology|August 19, 2003
Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferationValérie Capra, Aïda Habib, Maria Rosa Accomazzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2006
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparationsCarola Buccellati, Angelo Sala, Giuseppe Rossoni, et al.
Biochemical Pharmacology|November 11, 2005
CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptorsLiaman Mamedova, Valérie Capra, Maria Rosa Accomazzo, et al.
Pharmacological Research|December 2, 2015
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibitionMalvina Hoxha, Carola Buccellati, Valérie Capra, et al.
Biochemical Pharmacology|November 16, 2016
Impaired thromboxane receptor dimerization reduces signaling efficiency: A potential mechanism for reduced platelet function in vivoValérie Capra, Mario Mauri, Francesca Guzzi, et al.
Molecular Diagnosis & Therapy|December 13, 2006
G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveMiles D Thompson, Jun Takasaki, Valérie Capra, et al.
Prostaglandins & Other Lipid Mediators|April 4, 2015
Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT₂ receptorValérie Capra, Chiara Carnini, Maria Rosa Accomazzo, et al.
Chemmedchem|August 7, 2012
Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitorsMassimo Bertinaria, Mohammed Abrar Abdul Gaffar Shaikh, Carola Buccellati, et al.
Pageof 4